APA Zitierstil

Koh, J., Ko, J., Lim, S. Y., Bae, S., Huh, K., Cho, S. Y., . . . Lee, J. S. (2023). Triple immune modulator therapy for aberrant hyperinflammatory responses in severe COVID-19. Clinical immunology (Orlando, Fla.), 251, 109628. https://doi.org/10.1016/j.clim.2023.109628

Chicago Zitierstil

Koh, June-Young, et al. "Triple Immune Modulator Therapy for Aberrant Hyperinflammatory Responses in Severe COVID-19." Clinical Immunology (Orlando, Fla.) 251 (2023): 109628. https://dx.doi.org/10.1016/j.clim.2023.109628.

MLA Zitierstil

Koh, June-Young, et al. "Triple Immune Modulator Therapy for Aberrant Hyperinflammatory Responses in Severe COVID-19." Clinical Immunology (Orlando, Fla.), vol. 251, 2023, p. 109628.